Thursday, November 02, 2017 7:15:17 AM
EYES currently @ $1.08 PPS
Second Sight Medical Products, Inc. EYES has been given a $5.00 target price by HC Wainwright in a research report issued to clients and investors on Tuesday. The firm presently has a “buy” rating on the medical device company’s stock. HC Wainwright’s price target suggests a potential upside of 331.03% from the stock’s previous close.
EYES last issued its quarterly earnings data on Tuesday, August 1st. The medical device company reported ($0.13) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.14) by $0.01. Second Sight Medical Products had a negative return on equity of 168.49% and a negative net margin of 646.89%. The firm had revenue of $2.24 million during the quarter, compared to the consensus estimate of $1.43 million. During the same quarter in the previous year, the company posted ($0.17) EPS. The business’s revenue for the quarter was up 124.0% compared to the same quarter last year. On average, equities research analysts predict that Second Sight Medical Products will post ($0.55) earnings per share for the current year.
13.1% of Second Sight Medical Products shares are held by institutional investors
50.9% of Second Sight Medical Products shares are held by insiders. 13.1% of Second Sight Medical Products shares are held by institutional investors
50.9% of Second Sight Medical Products shares are held by insiders.
The posts contained on this account are my own opinions and are not recommendations or advise to buy or sell any security, stocks or other investments. These posts are for entertainment purposes only and are not considered to be facts or truth.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM